Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production

Virology

Volumn 335, Issue 1, 2005, Pages 10-21

  Li, Chengwen ^a   Samulski, R Jude ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

AAV; Replication; Yield

Indexed keywords

ADENOVIRUS VECTOR; HELICASE; PROTEIN CAPZ; VIRUS PROTEIN;

ADENO ASSOCIATED VIRUS; ANALYTIC METHOD; ARTICLE; DNA RECOMBINATION; DNA REPLICATION; GENE CONSTRUCT; GENE REPLICATION; PRIORITY JOURNAL; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; QUANTUM YIELD; SEROTYPE; VIRUS EXPRESSION; VIRUS GENE; VIRUS RECOMBINANT; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS TYPING; WILD TYPE;

EID: 16844363202     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.02.008     Document Type: Article

References (48)

1. J.M. Allen, D.J. Debelak, T.C. Reynolds, and A.D. Miller Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production J. Virol. 71 9 1997 6816 6822
2. U. Bantel-Schaal, and H. zur Hausen Characterization of the DNA of a defective human parvovirus isolated from a genital site Virology 134 1 1984 52 63
3. V. Blouin, N. Brument, E. Toublanc, I. Raimbaud, P. Moullier, and A. Salvetti Improving rAAV production and purification: towards the definition of a scaleable process J. Gene Med. 6 Suppl. 1 2004 S223 S228
4. L. Cao, Y. Liu, M.J. During, and W. Xiao High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids J. Virol. 74 24 2000 11456 11463
5. L. Cao, M. During, and W. Xiao Replication competent helper functions for recombinant AAV vector generation Gene Ther. 9 18 2002 1199 1206
6. G. Chadeuf, D. Favre, J. Tessier, N. Provost, P. Nony, J. Kleinschmidt, P. Moullier, and A. Salvetti Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome J. Gene Med. 2 4 2000 260 268
7. J.A. Chiorini, L. Yang, Y. Liu, B. Safer, and R.M. Kotin Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles J. Virol. 71 9 1997 6823 6833
8. J.A. Chiorini, S. Afione, and R.M. Kotin Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes J. Virol. 73 5 1999 4293 4298
9. J.A. Chiorini, F. Kim, L. Yang, and R.M. Kotin Cloning and characterization of adeno-associated virus type 5 J. Virol. 73 2 1999 1309 1319
10. K.R. Clark, F. Voulgaropoulou, D.M. Fraley, and P.R. Johnson Cell lines for the production of recombinant adeno-associated virus Hum. Gene Ther. 6 10 1995 1329 1341
11. K.R. Clark, X. Liu, J.P. McGrath, and P.R. Johnson Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses Hum. Gene Ther. 10 6 1999 1031 1039
12. J.E. Conway, C.M. Rhys, I. Zolotukhin, S. Zolotukhin, N. Muzyczka, G.S. Hayward, and B.J. Byrne High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap Gene Ther. 6 6 1999 986 993
13. J.Y. Dong, P.D. Fan, and R.A. Frizzell Quantitative analysis of the packaging capacity of recombinant adeno-associated virus Hum. Gene Ther. 7 17 1996 2101 2112
14. P.D. Fan, and J.Y. Dong Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV Hum. Gene Ther. 8 1 1997 87 98
15. E. Feudner, M. de Alwis, A.J. Thrasher, R.R. Ali, and S. Fauser Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system J. Virol. Methods 96 2 2001 97 105
16. T.R. Flotte, X. Barraza-Ortiz, R. Solow, S.A. Afione, B.J. Carter, and W.B. Guggino An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction Gene Ther. 2 1 1995 29 37
17. G.P. Gao, G. Qu, L.Z. Faust, R.K. Engdahl, W. Xiao, J.V. Hughes, P.W. Zoltick, and J.M. Wilson High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus Hum. Gene Ther. 9 16 1998 2353 2362
18. G.P. Gao, M.R. Alvira, L. Wang, R. Calcedo, J. Johnston, and J.M. Wilson Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy Proc. Natl. Acad. Sci. U.S.A. 99 18 2002 11854 11859
19. G.P. Gao, F. Lu, J.C. Sanmiguel, P.T. Tran, Z. Abbas, K.S. Lynd, J. Marsh, N.B. Spinner, and J.M. Wilson Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap Mol. Ther. 5 5 Pt. 1 2002 644 649
20. G. Gao, L.H. Vandenberghe, M.R. Alvira, Y. Lu, R. Calcedo, X. Zhou, and J.M. Wilson Clades of Adeno-associated viruses are widely disseminated in human tissues J. Virol. 78 12 2004 6381 6388
21. B. Georg-Fries, S. Biederlack, J. Wolf, and H. zur Hausen Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus Virology 134 1 1984 64 71
22. D. Grimm, A. Kern, K. Rittner, and J.A. Kleinschmidt Novel tools for production and purification of recombinant adenoassociated virus vectors Hum. Gene Ther. 9 18 1998 2745 2760
23. M. Hildinger, and A. Auricchio Advances in AAV-mediated gene transfer for the treatment of inherited disorders Eur. J. Hum. Genet. 12 4 2004 263 271
24. B. Hirt Selective extraction of polyoma DNA from infected mouse cell cultures J. Mol. Biol. 26 2 1967 365 369
25. L.A. Hunter, and R.J. Samulski Colocalization of adeno-associated virus Rep and capsid proteins in the nuclei of infected cells J. Virol. 66 1 1992 317 324
26. N. Inoue, and D.W. Russell Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors J. Virol. 72 9 1998 7024 7031
27. J. Li, R.J. Samulski, and X. Xiao Role for highly regulated rep gene expression in adeno-associated virus vector production J. Virol. 71 7 1997 5236 5243
28. X.L. Liu, K.R. Clark, and P.R. Johnson Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus Gene Ther. 6 2 1999 293 299
29. X. Liu, F. Voulgaropoulou, R. Chen, P.R. Johnson, and K.R. Clark Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines Mol. Ther. 2 4 2000 394 403
30. C.S. Manno, A.J. Chew, S. Hutchison, P.J. Larson, R.W. Herzog, V.R. Arruda, S.J. Tai, M.V. Ragni, A. Thompson, M. Ozelo, L.B. Couto, D.G. Leonard, F.A. Johnson, A. McClelland, C. Scallan, E. Skarsgard, A.W. Flake, M.A. Kay, K.A. High, and B. Glader AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B Blood 101 8 2003 2963 2972
31. T. Matsushita, S. Elliger, C. Elliger, G. Podsakoff, L. Villarreal, G.J. Kurtzman, Y. Iwaki, and P. Colosi Adeno-associated virus vectors can be efficiently produced without helper virus Gene Ther. 5 7 1998 938 945
32. P.E. Monahan, and R.J. Samulski AAV vectors: is clinical success on the horizon? Gene Ther. 7 1 2000 24 30
33. S. Muramatsu, H. Mizukami, N.S. Young, and K.E. Brown Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3 Virology 221 1 1996 208 217
34. C. Qiao, J. Li, A. Skold, X. Zhang, and X. Xiao Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes J. Virol. 76 4 2002 1904 1913
35. C. Qiao, B. Wang, X. Zhu, J. Li, and X. Xiao A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines J. Virol. 76 24 2002 13015 13027
36. E.A. Rutledge, C.L. Halbert, and D.W. Russell Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2 J. Virol. 72 1 1998 309 319
37. R.J. Samulski, L.S. Chang, and T. Shenk Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression J. Virol. 63 9 1989 3822 3828
38. R.S. Samulski, M. Sally, and N. Muzyczka Adeno-associated viral vectors T. Friedmann The development of human gene therapy 1999 Cold Spring Harbor NY
39. B.C. Schnepp, K.R. Clark, D.L. Klemanski, C.A. Pacak, and P.R. Johnson Genetic fate of recombinant adeno-associated virus vector genomes in muscle J. Virol. 77 6 2003 3495 3504
40. K. Sollerbrant, J. Elmen, C. Wahlestedt, J. Acker, H. Leblois-Prehaud, M. Latta-Mahieu, P. Yeh, and M. Perricaudet A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors J. Gen. Virol. 82 Pt. 9 2001 2051 2060
41. A. Srivastava, E.W. Lusby, and K.I. Berns Nucleotide sequence and organization of the adeno-associated virus 2 genome J. Virol. 45 2 1983 555 564
42. J.L. Stilwell, D.M. McCarty, A. Negishi, R. Superfine, and R.J. Samulski Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expression J. Virol. 77 23 2003 12881 12885
43. M. Urabe, C. Ding, and R.M. Kotin Insect cells as a factory to produce adeno-associated virus type 2 vectors Hum. Gene Ther. 13 16 2002 1935 1943
44. X.S. Wang, B. Khuntirat, K. Qing, S. Ponnazhagan, D.M. Kube, S. Zhou, V.J. Dwarki, and A. Srivastava Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination J. Virol. 72 7 1998 5472 5480
45. X. Xiao, J. Li, and R.J. Samulski Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector J. Virol. 70 11 1996 8098 8108
46. X. Xiao, J. Li, and R.J. Samulski Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus J. Virol. 72 3 1998 2224 2232
47. W. Xiao, N. Chirmule, S.C. Berta, B. McCullough, G. Gao, and J.M. Wilson Gene therapy vectors based on adeno-associated virus type 1 J. Virol. 73 5 1999 3994 4003
48. X. Zhang, M. De Alwis, S.L. Hart, F.W. Fitzke, S.C. Inglis, M.E. Boursnell, R.J. Levinsky, C. Kinnon, R.R. Ali, and A.J. Thrasher High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H Hum. Gene Ther. 10 15 1999 2527 2537